Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2009
  • Online publication date: August 2009

13 - Preventive strategies inbipolar disorders

from Section 5 - The first episode

Related content

Powered by UNSILO

References

Akiskal, H. S. (1981). Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the ‘borderline’ realm. Psychiatric Clinics of North America, 4, 25–46.
Akiskal, H. S. (1999). Bipolarity: beyond classic mania. Psychiatric Clinics of North America, 22, 512–703.
Akiskal, H. S., Downs, J., Jordan, P. et al. (1985). Affective disorders in referred children and younger siblings of manic depressives. Mode of onset and prospective course. Archives of General Psychiatry, 42, 996–1003.
Akiskal, H. S., Hantouche, E. G., Azorin, J. M. et al. (2003). Clinical characterization acute mania: data in 1090 patients – ‘EPIMAN-II’. Bipolar Disorders, 5(Suppl 1), 27.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA (2002). Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry, 159, 4–50.
Angst, J. (1985). Switch from depression to mania: a record study over decades between 1920 and 1982. Psychopathology, 18, 140–54.
Angst, J., Felder, W. & Lohmeyer, B. (1980). Course of schizoaffective psychoses: results of a followup study. Schizophrenia Bulletin, 6, 579–85.
Baethege, C., Smolka, M. N., Grushka, P. et al. (2003). Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatrica Scandinavica, 107, 260–7.
Baldessarini, R. J., Tondo, L. & Hennen, J. (2003). Treatment latency and previous episodes: relationship to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disorders, 5, 169–79.
Basco, M. R. & Rush, A. J. (1995). Compliance with pharmacology in mood disorders. Psychiatric Annals, 25, 269–79.
Bellivier, F., Golmard, J. L., Rietschel, M. et al. (2003). Age at onset in bipolar I affective disorder: further evidence for three subgroups. American Journal of Psychiatry, 160, 999–1001.
Berk, M. & Dodd, S. (2005). Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression? Medical Hypotheses, 65, 39–43.
Berk, M., Malhi, G. S., Mitchell, P. B. et al. (2004). Scale matters: the need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatrica Scandinavica, 422(Suppl), 39–45.
Berk, M., Berk, L., Moss, K., Dodd, S. & Malhi, G. S. (2006). Diagnosing bipolar disorder: how can we do it better? Medical Journal of Australia, 184, 459–62.
Berk, M., Malhi, G. S., Cahill, C. et al. (2007). The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disorder, 9, 571–9.
Burke, K. C., Burke, J. D., Regier, D. A., Rae, D. S. (1990). Age at onset of selected mental disorders in five community populations. Archives of General Psychiatry, 47, 511–18.
Carlson, G. A., Bromet, E. J. & Sievers, S. (2000). Phenomenology and outcome of subjects with early- and adult-onset psychotic mania. American Journal of Psychiatry, 157, 213–19.
Chang, K., Karchemskiy, A., Barnea-Goraly, N. et al. (2005). Reduced amygdala gray matter volume in familial pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 565–73.
Cochran, S. D. (1984). Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. Journal of Consulting and Clinical Psychology, 52, 873–8.
Colom, F., Vieta, E., Martinez-Aran, A. et al. (2003). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrence in bipolar patients whose disease is in remission. Archives of General Psychiatry, 60, 402–7.
Conus, P. & McGorry, P. D. (2002). First episode mania: a neglected priority for early intervention. Australian and New Zealand Journal of Psychiatry, 36, 158–72.
Conus, P., Abdel-Baki, A., Harrigan, S., Lambert, M. & McGorry, P. D. (2004). Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis. Journal of Affective Disorders, 81, 259–68.
Conus, P., Cotton, S., Abdel-Baki, A. & McGorry, P. D. (2006a). Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample. Bipolar Disorders, 8, 221–31.
Conus, P., Berk, M. & McGorry, P. D. (2006b). Pharmacological treatment in the early phase of bipolar disorders: what stage are we at? Australian and New Zealand Journal of Psychiatry, 40, 199–207.
Conus, P., Berk, M., Hallam, K., Lucas, N. & Ward, J. (2006c). The prodrome to first episode psychotic mania: results of a retrospective study. Schizophrenia Research, 86(Suppl), 37.
Coryell, W., Scheftner, W., Keller, M. et al. (1993). The enduring psychosocial consequences of mania and depression. American Journal of Psychiatry, 150, 720–7.
Craig, T. J., Grossman, S., Mojtabai, R. et al. (2004). Medication use patterns and 2-year outcome in first-admission bipolar disorders with psychotic features. Bipolar Disorders, 6, 406–15.
Dion, G. L., Tohen, M., Anthony, W. A. & Waternaux, C. S. (1988). Symptoms and functioning of patients with bipolar disorder six months after hospitalisation. Hospital and Community Psychiatry, 39, 652–7.
Egeland, J. A., Blumenthal, R. L., Nee, J., Sharpe, L. & Eddincott, J. (1987). Reliability and relationship of various ages of onset criteria for major affective disorders. Journal of Affective Disorders, 12, 159–65.
Egeland, J. A., Hostetter, A. M., Pauls, D. L. & Sussex, J. N. (2000). Prodromal symptoms before onset of manic–depressive disorder suggested by first hospital admission histories. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1245–52.
Ernst, C. L. & Goldberg, J. F. (2004). Clinical features related to age at onset in bipolar disorder. Journal of Affective Disorders, 82, 21–7.
Frank, E., Swartz, H. A., Mallinger, A. G. et al. (1999). Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. Journal of Abnormal Psychology, 108, 579–87.
Geller, B., Tillman, R., Craney, J. L. & Bolhofner, K. (2004). Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Archives of General Psychiatry, 61, 459–67.
Ghaemi, S. N., Ko, J. Y. & Goodwin, F. K. (2002). ‘Cade’s disease’ and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder.Canadian Journal of Psychiatry, 47, 125–34.
Goldberg, J. F. & Ernst, C. L. (2002). Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. Journal of Clinical Psychiatry, 63, 985–91.
Gonzalez-Pinto, A., Gonzalez, C., Enjuto, S. et al. (2004). Psychoeducation and cognitive-behavioral therapy in bipolar disorder: an update. Acta Psychiatrica Scandinavica, 109, 83–90.
Goodwin, F. K. & Jamison, K. R. (1990). Manic–Depressive Illness. New York: Oxford University Press.
Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology, revised. [DHEW Publication No. (ADM) 76–338.] Rockville MD: National Institute of Mental Health.
Harrow, M., Goldberg, J. F., Grossman, L. S. & Meltzer, H. Y. (1990). Outcome in manic disorders. Archives of General Psychiatry, 47, 665–71.
Hennion, J. P., el-Masri, M. A., Huff, M. O. & el-Mailakh, R. S. (2002). Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage. Bipolar Disorders, 4, 201–6.
Hirschfeld, R. M., Calabrese, J. R., Weissman, M. M. et al. (2003a). Screening for bipolar disorder in the community. Journal of Clinical Psychiatry, 64, 53–9.
Hirschfeld, R. M., Lewis, L. & Vornik, L. A. (2003b). Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic Depressive Association 2000 Survey of Individuals with Bipolar Disorder. Journal of Clinical Psychiatry, 64, 161–74.
Huxley, N. A., Parikh, S. V. & Baldessarini, R. J. (2000). Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harvard Review of Psychiatry, 8, 126–40.
International Early Psychosis Association Writing Group (2005). International clinical practice guidelines for early psychosis.British Journal of Psychiatry, 187(Suppl. 48), 120–4.
Jones, S. (2004). Psychotherapy of bipolar disorder: a review. Journal of Affective Disorders, 80, 101–14.
Jones, S. H., Sellwood, W. & McGovern, J. (2005). Psychological therapies for bipolar disorder: the role of model-driven approaches to therapy integration. Bipolar Disorders, 7, 22–32.
Joyce, P. R. (1984). Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia. Psychological Medicine, 14, 145–9.
Judd, L. L., Akiskal, H. S., Schettler, P. J. et al. (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry, 59, 530–7.
Keck, P. E., McElroy, S. L., Strakowski, S. M. et al. (1996). Factors associated with pharmacological noncompliance in patients with mania. Journal of Clinical Psychiatry, 57, 292–7.
Keck, P. E., McElroy, S. L., Strakowski, S. M. et al. (1998). 12-month outcome of patients with bipolar disorder following hospitalisation for a manic or mixed episode. American Journal of Psychiatry, 155, 646–52.
Keck, P. E., McElroy, S. L. & Strakowski, S. M. (2000). Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. Journal of Clinical Psychiatry, 61(Suppl 4), 33–8.
Kraepelin, E. (1919). Dementia Praecox. New York: Churchill Livingstone.
Kukopulos, A., Reginaldi, D., Laddomada, P. et al. (1980). Course of the manic–depressive cycle and changes caused by treatments. Pharmacopsychiatric Neuropsychopharmakologie 13, 156–67.
Lam, D. H., Watkins, R., Hayward, P. et al. (2003). A randomised controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Archives of General Psychiatry, 60, 145–52.
Lambert, M., Conus, P., Lambert, T. & McGorry, P. D. (2003). Pharmacotherapy of first-episode psychosis. Expert Opinion on Pharmacotherapy, 4, 717–50.
Lambert, M., Conus, P., Eide, P. et al. (2005). Treatment of early psychosis with olanzapine or risperidone (TEPOR study): a medical record review study in 367 non-affective and affective first-episode psychosis patients admitted to the Early Psychosis Prevention and Intervention Centre (EPPIC) in Melbourne Australia between 1998–2000. Pharmacopsychiatry, 38, 1–8.
Lieberman, J. A., Tollefson, G. D., Charles, C. et al. for the HGDH Study Group (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry, 62, 361–70.
Lish, J. D., Dime-Meenan, S., Whybrow, P. C., Price, R. A. & Hirschfeld, R. M. (1994). The National Depressive and Manic–depressive Association (DMDA) survey of bipolar members. Journal of Affective Disorders, 31, 281–94.
Macneil, C. (2004). Cognitive behavioural therapy with bipolar disorder: theory and reality with a first episode population. Schizophrenia Research, 70(Suppl 1), 92.
Mahli, G. S., Berk, M., Bourin, M. et al. (2005). Atypical mood stabilizers: a ‘typical’ role for atypical antipsychotics. Acta Psychiatrica Scandinavica, 426, 29–38.
Malla, A. M. & Norman, R. M. (2001). Treating psychosis: is there more to early intervention than intervening early? Canadian Journal of Psychiatry, 46, 645–8.
McGlashan, T. H. (1988). Adolescent versus adult onset of mania. American Journal of Psychiatry, 145, 221–3.
McGorry, P. D. (1995a). A treatment relevant classification of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 29, 555–8.
McGorry, P. D. (1995b). Psychoeducation in first episode psychosis: a therapeutic process. Psychiatry, 58, 313–28.
McGorry, P. D. & Jackson, H. J. (1999). The Recognition and Management of Early Psychosis: A Preventive Approach. Cambridge, UK: Cambridge University Press.
Mensink, G. J. R. & Sloof, C. J. (2004). Novel antipsychotics in bipolar and schizoaffective mania. Acta Psychiatrica Scandinavica, 109, 405–19.
Monkul, E. S., Malhi, G. S. & Soares, J. C. (2005). Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress? Australian and New Zealand Journal of Psychiatry, 39, 222–6.
National Early Psychosis Project (1998). Australian Guidelines for Early Psychosis. Melbourne: University of Melbourne.
Perry, A., Tarrier, N., Morriss, R., McCarthy, E. & Limb, K. (1999). Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. British Medical Journal, 318, 149–53.
Perugi, G., Micheli, C., Akiskal, H. S. et al. (2000). Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Comprehensive Psychiatry, 41, 13–18.
Post, R. M. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry, 149, 999–1010.
Post, R. M., Leverich, G. S., Altshuler, L. et al. (2003). An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disorders, 5, 310–19.
Prien, R. F. & Potter, W. Z. (1990). NIMH workshop report on treatment of bipolar disorder. Psychopharmacology Bulletin, 26, 409–27.
Remington, G., Kapur, S. & Zipursky, R. B. (1998). Pharmacotherapy of first-episode schizophrenia. British Journal of Psychiatry, 172, 66–70.
Royal Australian and New Zealand College of Psychiatrists (2005). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 39, 1–30.
Roy-Byrne, P., Post, R. M., Uhde, T. W., Porcu, T. & Davis, D. (1985). The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatrica Scandinavica, 317(Suppl), 1–34.
Scott, J. & Gutierrez, M. J. (2004). The current status of psychological treatments in bipolar disorders: a systematic review of relapse prevention. Bipolar Disorders, 6, 498–503.
Scott, J. & Tacchi, M. J. (2002). A pilot study of concordance therapy for individuals with bipolar disorders who are non-adherent with lithium prophylaxis. Bipolar Disorders, 4, 386–92.
Scott, J., Paykel, E., Morriss, R. et al. (2006). Cognitive–behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. British Journal of Psychiatry, 188, 313–20.
Sernyak, M. J., Griffin, R. A., Johnson, R. M. et al. (1994). Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptics. American Journal of Psychiatry, 151, 133–5.
Strakowski, S. M., Keck, P. E., McElroy, S. L. et al. (1998). Twelve-month outcome after first hospitalisation for affective psychosis. Archives of General Psychiatry, 55, 49–55.
Strober, M. & Carlson, G. (1982). Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Archives of General Psychiatry, 39, 549–55.
ten Have, M., Vollebergh, W., Bijl, R. & Nolen, W. A. (2002). Bipolar disorder in the general population in the Netherlands (prevalence, consequences and care utilisation): results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Journal of Affective Disorder, 68, 203–13.
Thompson, K. N., Conus, P., Ward, J. L. et al. (2003). The initial prodrome to bipolar affective disorder: prospective case studies. Journal of Affective Disorder, 77, 79–85.
Tohen, M., Waternaux, C. M. & Tsuang, M. T. (1990a). Outcome in mania. Archives of General Psychiatry, 47, 1106–11.
Tohen, M., Waternaux, C. M., Tsuang, M. T. & Hunt, A. T. (1990b). Four-year follow-up of twenty-four first-episode manic patients. Journal of Affective Disorders, 19, 79–86.
Tohen, M., Stoll, A. L., Strakowski, S. M. et al. (1992). The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schizophrenia Bulletin, 18, 273–82.
Tohen, M., Strakowski, S. M., Zarate, C. et al. (2000a). The McLean–Harvard First-Episode Project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biological Psychiatry, 48, 467–76.
Tohen, M., Hennen, J., Zarate, C. et al. (2000b). Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. American Journal of Psychiatry, 157, 220–8.
Tohen, M., Marneros, A., Bowden, C. L. et al. (2003a). Olanzapine vs. lithium in relapse prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial. Bipolar Disorders, 5(Suppl 1), 89.
Tohen, M., Bowden, C. L., Calabrese, J. R. et al. (2003b). Olanzapine’s efficacy for relapse prevention in bipolar disorder: a randomized double-blind, placebo-controlled 12-month clinical trial. Bipolar Disorders, 5(Suppl 1), 89.
Tohen, M., Chengappa, K., Suppes, T. et al. (2004). Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. British Journal of Psychiatry, 184, 337–45.
Tohen, M., Greil, W., Calabrese, J. R. et al. (2005). Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. American Journal of Psychiatry, 162, 1281–90.
Tryer, S. P. & Brittlebank, A. D. (1993). Misdiagnosis of bipolar affective disorder as personality disorder. Canadian Journal of Psychiatry, 38, 587–9.
Tsuang, M. T., Woolson, R. F. & Fleming, J. A. (1979). Long term outcome of major psychoses: I schizophrenia and affective disorders compared with psychiatrically symptom-free surgical controls. Archives of General Psychiatry, 36, 1295–301.
Verdoux, H., Gonzales, B., Takei, N. & Bourgeois, M. (1996). Survey of prescribing practice of antipsychotic maintenance treatment for manic–depressive outpatients. Journal of Affective Disorders, 38, 81–7.
Wozniak, J., Biederman, J. & Richards, J. A. (2001). Diagnostic and therapeutic dilemmas in the management of pediatric-onset bipolar disorder. Journal of Clinical Psychiatry, 62(Suppl 14), 10–15.
Yatham, L. N., Kennedy, S. H., O’Donovan, C. et al. for the Canadian Network for Mood and Anxiety Treatments. (2005) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders, 7(Suppl 3), 5–69.
Yung, A. R., Phillips, L. J., Yuen, H. P. et al. (2003). Psychosis prediction: 12-month follow up of a high-risk (‘prodromal’) group. Schizophrenia Research, 60, 21–32.
Zarate, C. A., Tohen, M., Land, M. & Cavanagh, S. (2000). Functional impairment and cognition in bipolar disorder. Psychiatric Quarterly, 71, 309–29.
Zis, A. P., Grof, P., Webster, M. & Goodwin, F. K. (1980). Prediction of relapse in recurrent affective disorder. Psychopharmacological Bulletin, 16, 47–9.